David Esposito joins Phadia
This article was originally published in Clinica
Swedish allergy testing specialist Phadia has appointed David Esposito senior vice-president of US sales and marketing. Mr Esposito previously worked for Merck for 16 years, where he was most recently executive director for the respiratory marketing team. He will now help expand marketing efforts to increase awareness of Uppsala-based Phadia's ImmunoCAP Specific IgE blood test in the US. The diagnostic helps doctors to diagnose allergic triggers that underlie a patient's asthma, rhinitis or eczema.